A cannabis-derived substance is now specifically listed as a Schedule I drug

The US Drug Enforcement Administration has created a specific listing for hexahydrocannabinol (HHC) as a Schedule I controlled substance. This means HHC is now explicitly illegal under federal law, rather than being covered by a broader category.

For years, the legal status of cannabis-derived substances like HHC has been ambiguous, leading to a gray market where they are sold legally in some states. This specific listing removes that ambiguity for HHC. Companies that produce or sell HHC now face clear federal penalties.